FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to the pharmaceutical industry, namely to a therapeutic anti-inflammatory composition, which contains one or several polyphenols and two or more carotenoids, which are selected from the group, consisting of lutein, lycopene and β-carotene, where the polyphenols are selected from the group consisting of carnosic acid, quercetin, resveratrol and gallic acid, in a specified quantity; to the method of inhibition or reduction of superoxide-ions formation, NO, TNF-α and/or PGE2 in a subject-mammal, which the said composition is introduced to; to the method of treating pathological conditions, in which superoxide-ions, NO, TNF-α and/or PGE2 function as a modulator or mediator of the said condition of the subject-mammal, which the said composition is introduced to; to the application of a combination of one or several polyphenols and two or more carotenoids, selected from the group, which consists of lutein, lycopene and β-carotene, where the polyphenols are selected from the group, consisting of carnosic acid, quercetin, resveratrol and gallic acid, in a specified quantity.
EFFECT: synergetic interaction of the polyphenol compounds with carotenoids in the inhibition of inflammation pathways is achieved.
28 cl, 11 dwg, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SYNERGISTIC COMPOSITIONS AND METHODS | 2012 |
|
RU2657594C2 |
| BIOLOGICALLY ACTIVE TOMATO COMPOSITION WITH REDUCED LICOPINE CONTENT | 2015 |
|
RU2748400C2 |
| SYNERGETIC COMBINATIONS FOR TREATING HYPERTENSION | 2008 |
|
RU2459617C2 |
| CAROTINOID COMPOSITION AND METHOD OF SKIN PROTECTION | 2002 |
|
RU2341252C2 |
| PHARMACEUTICAL OR DIETETIC COMPOSITION FOR REDUCING MAMMAL BLOOD IGF-I LEVEL AND METHOD FOR REDUCING IGF-I LEVEL | 2000 |
|
RU2242220C2 |
| CAROTINOID-CONTAINING ANTI-ATHEROSCLEROTIC COMPOSITION AND METHOD FOR INHIBITION OF OXIDATION OF LOW DENSITY LIPOPROTEIN (LDL) | 2002 |
|
RU2288707C2 |
| METHODS OF ORAL HEALTH PROMOTION IN ANIMALS | 2005 |
|
RU2430629C2 |
| IMPROVED METHOD FOR PRODUCING LYCOPENE VIA FERMENTATION OF SELECTED STRAINS Blakeslea trispora AND USING THUS OBTAINED LYCOPENE | 2002 |
|
RU2296161C2 |
| ENTERALLY ADMINISTRATED SUPPLEMENT FOR PARENTERAL NUTRITION OR PARTIAL ENTERAL/ORAL NUTRITION IN CASE WITH CRITICALLY ILL PATIENTS, CHRONIC PATIENTS AND PATIENTS WITH DEFICIENT NUTRITION | 2001 |
|
RU2295952C2 |
| IMMUNOMODULATORY MESENCHYMAL STEM CELLS | 2020 |
|
RU2828728C2 |
